跳至主要内容
临床试验/CTRI/2013/08/003879
CTRI/2013/08/003879已完成2 期

Homoeopathic treatment of vitiligo: an open observational pilot study

Mahesh Bhattacharyya Homeopathic Medical College and Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age between 5 yrs to 80 yrs
  • 2. Both sexes
  • 3. Giving written informed consent to join the study
  • 4. VETF stage 1 & 2, spread (+1) to (-1), extent any.
  • 5. VASI residual depigmentation 25-75%; units any.
  • 6. Patients already undergoing regular oral/topical conventional therapy for vitiligo, provided the medications are stopped completely for at last 1 month prior registering for the study
  • Patients on life-saving conventional drug therapies, e.g. anti-diabetics, anti-hypertensives, thyroid drugs etc. for co-morbidities under control, will be continued.

排除标准

  • 1. VETF stage 0 and 3
  • 2. VASI residual depigmentation 100%, 90% and 10%
  • 3. Uncontrolled, unevaluated and/or complicated diabetes mellitus, hypertension, and other co-morbidities
  • 4. Cases with other systemic unevaluated or uncontrolled diseases like cardiovascular, renal, gastro-intestinal, endocrinal, gynecological diseases etc. or systemic infections affecting quality of life or on other treatment therapies
  • 5. Pregnancy, lactation and likelihood of pregnancy
  • 6. Not giving consent to join the study

研究者

发起方
Mahesh Bhattacharyya Homeopathic Medical College and Hospital

相似试验